What do physicists, chemists, mathematicians and biologists have in common? One of the answers at Cambridge is a shared interest in unravelling the processes behind neurodegenerative diseases such as Alzheimer's, Parkinson's and Motor Neurone Disease.
From campus to community, the worlds of mental health research and medical practice are being brought together by a collaboration involving researchers, health and social care providers, and the patients themselves.
Despite recent dramatic reductions in cot death rates in the UK, and the development of sophisticated screening for Down’s syndrome, preventing stillbirth is proving tougher to tackle. Now, a major study under way at Cambridge could change all that.
Research programmes at the Cambridge Institute of Public Health focus on common chronic disorders. Currently under the spotlight is dementia and a major new project that will underpin improved prevention, screening and patient care.
Eight leading academic centres, including the Cambridge Institute for Public Health (CIPH), are to begin a collaboration that will play a key role in increasing the evidence base for effective public health practice.
A new Cambridge-led study has examined the past 60 years of incidence data on psychotic disorders in England in the hope that the data can reveal clues about the possible social factors which appear to underpin such conditions.
Scan can detect 5p-sized growth that causes hypertension.
Cambridge BioResource provides a new approach to understanding why some of us suffer from certain common diseases while others don't.